Consolidation Chemotherapy
Sponsors
Hospital Israelita Albert Einstein, Wake Forest University Health Sciences, Jing Jin, M.D., State Scientific Centre of Coloproctology, Russian Federation, Institute of Oncology Ljubljana
Conditions
Acute Myeloid LeukemiaAcute Myeloid Leukemia (AML)ChemoradiotherapyChemotherapyChemotherapy Side EffectsLocally Advanced Rectal CancerLocally Advanced Rectal CarcinomaLow Anterior Resection Syndrome
Phase 2
Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms
CompletedNCT02084563
Start: 2012-10-31End: 2016-11-30Updated: 2016-11-08
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
NCT04664504
Start: 2020-12-01End: 2025-12-01Target: 150Updated: 2021-06-08
Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence
RecruitingNCT05054959
Start: 2021-06-24End: 2027-12-31Target: 62Updated: 2021-09-23
Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer
CompletedNCT05274945
Start: 2020-01-01End: 2022-01-01Updated: 2022-03-11
Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer
CompletedNCT05792735
Start: 2023-04-11End: 2025-01-31Updated: 2025-02-05
Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
RecruitingNCT06758830
Start: 2025-01-07End: 2029-12-27Target: 400Updated: 2025-01-09
Phase 3
Phase 4
Unknown Phase
Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial
RecruitingNCT05496491
Start: 2022-08-30End: 2026-08-30Target: 84Updated: 2024-10-08
Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
RecruitingNCT06246344
Start: 2023-12-01End: 2028-12-01Target: 128Updated: 2025-03-12